Latest Articles

Publication Date
Identification of hub biomarkers and immune cell infiltrations participating in the pathogenesis of endometriosis.

Endometriosis (EM) is a chronic disease that can cause pain and infertility in patients. As is well known, immune cell infiltrations (ICIs) play important roles in the pathogenesis of EM. …

Published: Jan. 22, 2025, midnight
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer - Yahoo Finance

GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer Yahoo Finance

Published: Jan. 21, 2025, 2:35 p.m.
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer - Medical Dialogues

GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Medical Dialogues

Published: Jan. 21, 2025, 8 a.m.
Social media activism and women's health: Endometriosis awareness and support.

While endometriosis is estimated to affect 1 in 10 women globally, awareness of the disease as well as research and funding to fight the disease remains lacking as compared with …

Published: Jan. 21, 2025, midnight
Neutrophils initiate pro-inflammatory immune responses in early endometriosis lesion development.

Endometriosis is a chronic gynecological disease that affects 1 in 10 reproductive-aged women. Most studies investigate established disease; however, the initiation and early events in endometriotic lesion development remain poorly …

Published: Jan. 21, 2025, midnight
Ovarian Endometrioma Disrupts Oocyte-Cumulus Communication and Mitochondrial Function, With Melatonin Mitigating the Effects.

Ovarian endometrioma (OEM), a particularly severe form of endometriosis, is an oestrogen-dependent condition often associated with pain and infertility. The mechanisms by which OEM impairs fertility, particularly through its direct …

Published: Jan. 21, 2025, midnight
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE

GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE

Published: Jan. 20, 2025, 12:33 p.m.
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer - FirstWord Pharma

GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma

Published: Jan. 20, 2025, 7:14 a.m.
A cRGD-modified liposome for targeted delivery of artesunate to inhibit angiogenesis in endometriosis.

Currently, hormonal therapy for endometriosis faces challenges in achieving a balance between treatment and preserving the chance of pregnancy. Therefore, the development of non-hormonal therapy holds significant clinical importance. Angiogenesis …

Published: Jan. 20, 2025, midnight
Understanding Deep Endometriosis: From Molecular to Neuropsychiatry Dimension.

Endometriosis is a widely spread disease that affects about 8% of the world's female population. This condition may be described as a spread of endometrial tissue apart from the uterine …

Published: Jan. 20, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!